Toxoplasma gondii remains a serious cause of morbidity and mortality in ind
ividuals that are immunosuppressed, patients with AIDS in particular. The c
ellular immune response, especially by gamma interferon (IFN-gamma)-produci
ng CD8(+) T cells, is an essential component of protective immunity against
the parasite. In the present study the role of CD8(+) T cells during the r
eactivation of Toxoplasma infection in an immunocompromised murine model wa
s evaluated, Chronically infected mice were challenged with LP-BM5 virus, a
nd the kinetics of CD8(+) T-cell function was studied. At 10 weeks after vi
ral infection, mice showed obvious signs of systemic illness and began to d
ie, At this stage, CD8(+) T cells were unresponsive to antigenic stimulatio
n and unable to kill Toxoplasma-infected targets. IFN-gamma production by t
he CD8(+) T cells from dual-infected animals reached background levels, and
a dramatic fall in the frequency of precursor cytotoxic T lymphocytes was
observed. Histopathological analysis of the tissues demonstrated signs of d
isseminated toxoplasmosis as a result of reactivation of infection. However
, treatment of the dual-infected animals with immune CD8(+) T cells at 5 we
eks post-LP-BM5 challenge prevented the reactivation of toxoplasmosis, and
mice continued to live. Our study for the first time demonstrates a therape
utic role for CD8(+) T cells against an opportunistic infection in an immun
ocompromised state.